Contineum Therapeutics, Inc. Class A Common Stock
CTNM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $330 | $103 | $181 | $379 |
| - Cash | $43 | $21 | $22 | $22 |
| + Debt | $5 | $6 | $6 | $6 |
| Enterprise Value | $293 | $88 | $164 | $363 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$13 | -$16 | -$18 | -$14 |
| % Margin | – | – | – | – |
| Net Income | -$13 | -$16 | -$16 | -$15 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.45 | -0.62 | -0.62 | -0.65 |
| % Growth | 27.4% | 0% | 4.6% | – |
| Operating Cash Flow | -$12 | -$16 | -$14 | -$10 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$12 | -$16 | -$14 | -$10 |